Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 95

1.

A New Benzopyranyl Cadenane Sesquiterpene and Other Antiplasmodial and Cytotoxic Metabolites from Cleistochlamys kirkii.

Nyandoro SS, Maeda G, Munissi JJE, Gruhonjic A, Fitzpatrick PA, Lindblad S, Duffy S, Pelletier J, Pan F, Puttreddy R, Avery VM, Erdélyi M.

Molecules. 2019 Jul 29;24(15). pii: E2746. doi: 10.3390/molecules24152746.

2.

Halogen Bonding Helicates Encompassing Iodonium Cations.

Vanderkooy A, Gupta AK, Földes T, Lindblad S, Orthaber A, Pápai I, Erdélyi M.

Angew Chem Int Ed Engl. 2019 Jul 1;58(27):9012-9016. doi: 10.1002/anie.201904817. Epub 2019 Jun 6.

PMID:
31074942
3.

Halogen Bond Asymmetry in Solution.

Lindblad S, Mehmeti K, Veiga AX, Nekoueishahraki B, Gräfenstein J, Erdélyi M.

J Am Chem Soc. 2018 Oct 17;140(41):13503-13513. doi: 10.1021/jacs.8b09467. Epub 2018 Oct 4.

4.

Creating a culture of health: evolving healthcare systems and patient engagement.

Lindblad S, Ernestam S, Van Citters AD, Lind C, Morgan TS, Nelson EC.

QJM. 2017 Mar 1;110(3):125-129. doi: 10.1093/qjmed/hcw188. Review. No abstract available.

PMID:
27803364
5.

Patient focused registries can improve health, care, and science.

Nelson EC, Dixon-Woods M, Batalden PB, Homa K, Van Citters AD, Morgan TS, Eftimovska E, Fisher ES, Ovretveit J, Harrison W, Lind C, Lindblad S.

BMJ. 2016 Jul 1;354:i3319. doi: 10.1136/bmj.i3319. No abstract available.

6.

Patient-initiated appointments compared with standard outpatient care for rheumatoid arthritis: a randomised controlled trial.

Fredriksson C, Ebbevi D, Waldheim E, Lindblad S, Ernestam S.

RMD Open. 2016 Mar 16;2(1):e000184. doi: 10.1136/rmdopen-2015-000184. eCollection 2016.

7.

Patient reported outcome measures in practice.

Nelson EC, Eftimovska E, Lind C, Hager A, Wasson JH, Lindblad S.

BMJ. 2015 Feb 10;350:g7818. doi: 10.1136/bmj.g7818. No abstract available.

PMID:
25670183
8.

Body awareness in persons diagnosed with rheumatoid arthritis.

Lööf H, Johansson UB, Henriksson EW, Lindblad S, Bullington J.

Int J Qual Stud Health Well-being. 2014 Oct 31;9:24670. doi: 10.3402/qhw.v9.24670. eCollection 2014.

9.

Fear-avoidance beliefs about physical activity in adults with rheumatoid arthritis.

Lööf H, Demmelmaier I, Henriksson EW, Lindblad S, Nordgren B, Opava CH, Johansson UB.

Scand J Rheumatol. 2015;44(2):93-9. doi: 10.3109/03009742.2014.932432. Epub 2014 Sep 15.

10.

Accelerating translational research by clinically driven development of an informatics platform--a case study.

Abugessaisa I, Saevarsdottir S, Tsipras G, Lindblad S, Sandin C, Nikamo P, Ståhle M, Malmström V, Klareskog L, Tegnér J.

PLoS One. 2014 Sep 9;9(9):e104382. doi: 10.1371/journal.pone.0104382. eCollection 2014.

11.

Implementation of the CDC translational informatics platform--from genetic variants to the national Swedish Rheumatology Quality Register.

Abugessaisa I, Gomez-Cabrero D, Snir O, Lindblad S, Klareskog L, Malmström V, Tegnér J.

J Transl Med. 2013 Apr 2;11:85. doi: 10.1186/1479-5876-11-85.

12.

[Quality registries--the patient's and the physician's workshop].

Lindblad S, Carlsson A.

Lakartidningen. 2013 Feb 13-19;110(7):365-6. Swedish. No abstract available.

PMID:
23513387
13.

Continuous innovation: developing and using a clinical database with new technology for patient-centred care--the case of the Swedish quality register for arthritis.

Ovretveit J, Keller C, Hvitfeldt Forsberg H, Essén A, Lindblad S, Brommels M.

Int J Qual Health Care. 2013 Apr;25(2):118-24. doi: 10.1093/intqhc/mzt002. Epub 2013 Jan 29.

PMID:
23360809
14.

Incidence of rheumatoid arthritis in Sweden: a nationwide population-based assessment of incidence, its determinants, and treatment penetration.

Eriksson JK, Neovius M, Ernestam S, Lindblad S, Simard JF, Askling J.

Arthritis Care Res (Hoboken). 2013 Jun;65(6):870-8. doi: 10.1002/acr.21900.

15.

Innovation as emergence in healthcare: unpacking change from within.

Essén A, Lindblad S.

Soc Sci Med. 2013 Sep;93:203-11. doi: 10.1016/j.socscimed.2012.08.035. Epub 2012 Sep 12.

PMID:
23021848
16.

Development and psychometric testing of the Swedish version of the Body Awareness Questionnaire.

Lööf H, Johansson UB, Henriksson EW, Lindblad S, Saboonchi F.

J Adv Nurs. 2013 Jul;69(7):1643-51. doi: 10.1111/jan.12020. Epub 2012 Sep 20.

PMID:
22994423
17.

The cost-effectiveness of TNF-inhibitors for the treatment of rheumatoid arthritis in Swedish clinical practice.

Lekander I, Borgström F, Lysholm J, van Vollenhoven RF, Lindblad S, Geborek P, Kobelt G.

Eur J Health Econ. 2013 Dec;14(6):863-73. doi: 10.1007/s10198-012-0431-6. Epub 2012 Sep 19.

PMID:
22990378
18.

The medium is the (health) measure: patient engagement using personal technologies.

Wasson JH, Forsberg HH, Lindblad S, Mazowita G, McQuillen K, Nelson EC.

J Ambul Care Manage. 2012 Apr-Jun;35(2):109-17. doi: 10.1097/JAC.0b013e31824a235e.

PMID:
22415284
19.

The N-methyl-d-aspartic acid receptor antagonist memantine ameliorates and delays the development of arthritis by enhancing regulatory T cells.

Lindblad SS, Mydel P, Hellvard A, Jonsson IM, Bokarewa MI.

Neurosignals. 2012;20(2):61-71. doi: 10.1159/000329551. Epub 2011 Dec 1.

20.

Variants of gene for microsomal prostaglandin E2 synthase show association with disease and severe inflammation in rheumatoid arthritis.

Korotkova M, Daha NA, Seddighzadeh M, Ding B, Catrina AI, Lindblad S, Huizinga TW, Toes RE, Alfredsson L, Klareskog L, Jakobsson PJ, Padyukov L.

Eur J Hum Genet. 2011 Aug;19(8):908-14. doi: 10.1038/ejhg.2011.50. Epub 2011 Mar 30.

21.

Effects of GSTM1 in rheumatoid arthritis; results from the Swedish EIRA study.

Lundström E, Hartshorne T, Li K, Lindblad S, Wick MC, Bengtsson C, Alfredsson L, Klareskog L, Padyukov L.

PLoS One. 2011 Mar 22;6(3):e17880. doi: 10.1371/journal.pone.0017880.

22.

Managing health care decisions and improvement through simulation modeling.

Forsberg HH, Aronsson H, Keller C, Lindblad S.

Qual Manag Health Care. 2011 Jan-Mar;20(1):15-29. doi: 10.1097/QMH.0b013e3182033bdc. Review.

PMID:
21192204
23.

Ten years with biologics: to whom do data on effectiveness and safety apply?

Simard JF, Arkema EV, Sundström A, Geborek P, Saxne T, Baecklund E, Coster L, Dackhammar C, Jacobsson L, Feltelius N, Lindblad S, Rantapää-Dahlqvist S, Klareskog L, van Vollenhoven RF, Neovius M, Askling J.

Rheumatology (Oxford). 2011 Jan;50(1):204-13. doi: 10.1093/rheumatology/keq326. Epub 2010 Nov 16.

PMID:
21084326
24.
25.

Analysis of neuropeptide S receptor gene (NPSR1) polymorphism in rheumatoid arthritis.

D'Amato M, Zucchelli M, Seddighzadeh M, Anedda F, Lindblad S, Kere J, Alfredsson L, Klareskog L, Padyukov L.

PLoS One. 2010 Feb 22;5(2):e9315. doi: 10.1371/journal.pone.0009315.

26.

Cancer risk in patients with rheumatoid arthritis treated with anti-tumor necrosis factor alpha therapies: does the risk change with the time since start of treatment?

Askling J, van Vollenhoven RF, Granath F, Raaschou P, Fored CM, Baecklund E, Dackhammar C, Feltelius N, Cöster L, Geborek P, Jacobsson LT, Lindblad S, Rantapää-Dahlqvist S, Saxne T, Klareskog L.

Arthritis Rheum. 2009 Nov;60(11):3180-9. doi: 10.1002/art.24941.

27.

Feed forward systems for patient participation and provider support: adoption results from the original US context to Sweden and beyond.

Hvitfeldt H, Carli C, Nelson EC, Mortenson DM, Ruppert BA, Lindblad S.

Qual Manag Health Care. 2009 Oct-Dec;18(4):247-56. doi: 10.1097/QMH.0b013e3181bee32e.

PMID:
19851232
28.

[The debate on National Quality Registries: The criticism shows a need of increased knowledge of the purpose of the registries].

Garellick G, Lindahl B, Gudbjörnsdottir S, Lindblad S, Lundström M, Spångberg K, Rehnqvist N, Rolfson O.

Lakartidningen. 2009 Jun 24-Jul 7;106(26-27):1749-51. Swedish. No abstract available.

PMID:
19731738
29.

Smoking and nicotine exposure delay development of collagen-induced arthritis in mice.

Lindblad SS, Mydel P, Jonsson IM, Senior RM, Tarkowski A, Bokarewa M.

Arthritis Res Ther. 2009;11(3):R88. doi: 10.1186/ar2728. Epub 2009 Jun 11.

30.

Evaluation of arthroscopy and macroscopic scoring.

af Klint E, Catrina AI, Matt P, Neregråd P, Lampa J, Ulfgren AK, Klareskog L, Lindblad S.

Arthritis Res Ther. 2009;11(3):R81. doi: 10.1186/ar2714. Epub 2009 Jun 2.

31.

Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: relative risks and time trends in the Swedish Biologics Register.

Askling J, Baecklund E, Granath F, Geborek P, Fored M, Backlin C, Bertilsson L, Cöster L, Jacobsson LT, Lindblad S, Lysholm J, Rantapää-Dahlqvist S, Saxne T, van Vollenhoven R, Klareskog L, Feltelius N.

Ann Rheum Dis. 2009 May;68(5):648-53. doi: 10.1136/ard.2007.085852. Epub 2008 May 8.

PMID:
18467516
32.

Charting the possible impact of national guidelines on the management of rheumatoid arthritis.

Carli C, Bridges JF, Ask J, Lindblad S; Swedish Rheumatoid Arthritis Register.

Scand J Rheumatol. 2008 May-Jun;37(3):188-93. doi: 10.1080/03009740701874436.

PMID:
18465453
33.

Towards a physiologically based diagnosis of anorexia nervosa and bulimia nervosa.

Hatch KA, Spangler DL, Backus EM, Balagna JT, Burns KS, Guzman BS, Hubbard MJ, Lindblad SL, Roeder BL, Ryther NE, Seawright MA, Tyau JN, Williams D.

Expert Rev Mol Diagn. 2007 Nov;7(6):845-57. Review.

PMID:
18020913
34.

System characteristics of healthcare organizations conducting successful improvements.

Olsson J, Elg M, Lindblad S.

J Health Organ Manag. 2007;21(3):283-96.

PMID:
17713188
35.

Time-dependent increase in risk of hospitalisation with infection among Swedish RA patients treated with TNF antagonists.

Askling J, Fored CM, Brandt L, Baecklund E, Bertilsson L, Feltelius N, Cöster L, Geborek P, Jacobsson LT, Lindblad S, Lysholm J, Rantapää-Dahlqvist S, Saxne T, van Vollenhoven RF, Klareskog L.

Ann Rheum Dis. 2007 Oct;66(10):1339-44. Epub 2007 Jan 29. Erratum in: Ann Rheum Dis. 2007 Nov;66(11):1548.

36.

Predicting physical activity and general health perception among patients with rheumatoid arthritis.

Eurenius E, Brodin N, Lindblad S, Opava CH; PARA Study Group.

J Rheumatol. 2007 Jan;34(1):10-5.

PMID:
17216673
37.

Ethanol prevents development of destructive arthritis.

Jonsson IM, Verdrengh M, Brisslert M, Lindblad S, Bokarewa M, Islander U, Carlsten H, Ohlsson C, Nandakumar KS, Holmdahl R, Tarkowski A.

Proc Natl Acad Sci U S A. 2007 Jan 2;104(1):258-63. Epub 2006 Dec 21.

38.

Swedish registers to examine drug safety and clinical issues in RA.

Askling J, Fored CM, Geborek P, Jacobsson LT, van Vollenhoven R, Feltelius N, Lindblad S, Klareskog L.

Ann Rheum Dis. 2006 Jun;65(6):707-12. Epub 2006 Jan 13. Review.

39.
40.
41.

The one-person randomized controlled trial.

Olsson J, Terris D, Elg M, Lundberg J, Lindblad S.

Qual Manag Health Care. 2005 Oct-Dec;14(4):206-16.

PMID:
16227864
42.

Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden.

Askling J, Fored CM, Brandt L, Baecklund E, Bertilsson L, Cöster L, Geborek P, Jacobsson LT, Lindblad S, Lysholm J, Rantapää-Dahlqvist S, Saxne T, Romanus V, Klareskog L, Feltelius N.

Arthritis Rheum. 2005 Jul;52(7):1986-92.

43.

Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists.

Askling J, Fored CM, Baecklund E, Brandt L, Backlin C, Ekbom A, Sundström C, Bertilsson L, Cöster L, Geborek P, Jacobsson LT, Lindblad S, Lysholm J, Rantapää-Dahlqvist S, Saxne T, Klareskog L, Feltelius N.

Ann Rheum Dis. 2005 Oct;64(10):1414-20. Epub 2005 Apr 20.

44.
45.

Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonists.

Askling J, Fored CM, Brandt L, Baecklund E, Bertilsson L, Feltelius N, Cöster L, Geborek P, Jacobsson LT, Lindblad S, Lysholm J, Rantapää-Dahlqvist S, Saxne T, Klareskog L.

Ann Rheum Dis. 2005 Oct;64(10):1421-6. Epub 2005 Apr 13.

46.

Clinical and radiological disease-course in a Swedish DMARD-treated early RA-inception cohort: an observational study.

Wick MC, Lindblad S, Weiss RJ, Klareskog L, van Vollenhoven RF.

Scand J Rheumatol. 2004;33(6):380-4.

PMID:
15794195
47.
48.

Do team gymnasts compete in spite of symptoms from an injury?

Harringe ML, Lindblad S, Werner S.

Br J Sports Med. 2004 Aug;38(4):398-401.

49.

Results from a nationwide postmarketing cohort study of patients in Sweden treated with etanercept.

Feltelius N, Fored CM, Blomqvist P, Bertilsson L, Geborek P, Jacobsson LT, Lindblad S, Lysholm J, Rantapää-Dahlqvist S, Saxne T, Klareskog L; ARTIS Group.

Ann Rheum Dis. 2005 Feb;64(2):246-52. Epub 2004 Jun 18.

50.

Relationship between inflammation and joint destruction in early rheumatoid arthritis: a mathematical description.

Wick MC, Lindblad S, Klareskog L, Van Vollenhoven RF.

Ann Rheum Dis. 2004 Jul;63(7):848-52.

Supplemental Content

Loading ...
Support Center